Diagnosis and management of patients with bipolar disorder in primary care

British Journal of General Practice

Volumn 55, Issue 518, 2005, Pages 662-664

  Berk, Michael ^a,b,c   Dodd, Seetal ^a,c   Berk, Lesley ^a,d   Opie, Jane ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

^c BARWON HEALTH   (Australia)

^d FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLOZAPINE; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; OLANZAPINE; QUETIAPINE; RISPERIDONE; VALPROIC ACID; ZIPRASIDONE;

BEHAVIOR THERAPY; BIPOLAR DISORDER; COGNITIVE THERAPY; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; EDITORIAL; HUMAN; MEDICAL PROFESSION; PATIENT EDUCATION; PRESCRIPTION; PREVALENCE; PRIMARY MEDICAL CARE; PROFESSIONAL PRACTICE; QUALITY ADJUSTED LIFE YEAR; RISK ASSESSMENT; SOCIAL PSYCHOLOGY; SYMPTOMATOLOGY; WORLD HEALTH ORGANIZATION;

EID: 24344488391     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (29)

1. Akiskal HS, Bourgeois ML, Angst J, et al. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affect Disord 2000; 59 Suppl 1: S5-S30.
2. Piver A, Yatham LN, Lam RW. Bipolar spectrum disorders. New perspectives. Can Fam Physician 2002; 48: 896-904.
3. Suppes T, Dennehy EB, Gibbons EW. The longitudinal course of bipolar disorder. J Clin Psychiatry 2000; 61 Suppl 9: 23-30.
4. Jamison KR. Suicide and bipolar disorder. J Clin Psychiatry 2000; 61 Suppl 9: 47-51.
5. Hinkle P. Bipolar illness in primary care: an overview. Lippincotts Prim Care Pract 2000; 4(2): 163-173.
6. Lish JD, Dime-Meenan S, Whybrow PC, et al. The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members. J Affect Disord 1994; 31(4): 281-294.
7. Andrews G, Issakidis C, Sanderson K, et al. Utilising survey data to inform public policy: comparison of the cost-effectiveness of treatment of ten mental disorders. Br J Psychiatry 2004; 184: 526-533.
8. Manning JS. Bipolar disorder in primary care. J Fam Pract 2003; Suppl: S6-9.
9. Sachs GS, Yan LJ, Swann AC, Allen MH. Integration of suicide prevention into outpatient management of bipolar disorder. J Clin Psychiatry 2001; 62 Suppl 25: 3-11.
10. Bowden CL, Brugger AM, Swann AC, et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA 1994; 271(12): 918-924.
11. Freeman TW, Clothier JL, Pazzaglia P, et al. A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry 1992; 149(1): 108-111.
12. Goodwin FK, Jamison KR. Manic-depressive illness. New York, NY: Oxford University Press, 1990.
13. Davis JM, Janicak PG, Hogan DM. Mood stabilizers in the prevention of recurrent affective disorders: a meta-analysis. Acta Psychiatr Scand 1999; 100(6): 406-417.
14. Baldessarini RJ, Tondo L. Does lithium treatment still work? Evidence of stable responses over three decades. Arch Gen Psychiatry 2000; 57(2): 187-190.
15. Bowden CL, Calabrese JR, McElroy SL, et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry 2000; 57(5): 481-489.
16. Keck PE, Jr, Mendlwicz J, Calabrese JR, et al. A review of randomized, controlled clinical trials in acute mania. J Affect Disord 2000; 59 Suppl 1: S31-S37.
17. Kleindienst N, Greil W. Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study. Neuropsychobiology 2000; 42 Suppl 1: 2-10.
18. Calabrese JR, Bowden CL, Sachs GS, et al. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry 1999; 60(2): 79-88.
19. Bowden CL, Calabrese JR, Sachs G, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003; 60(4): 392-400.
20. Ghaemi SN, Lenox MS, Baldessarini RJ. Effectiveness and safety of long-term antidepressant treatment in bipolar disorder. J Clin Psychiatry 2001; 62(7): 565-569.
21. Calabrese JR, Sullivan JR, Bowden CL, et al. Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management. J Clin Psychiatry 2002; 63(11): 1012-1019.
22. Vieta E, Martinez-Aran A, Goikolea JM, et al. A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers. J Clin Psychiatry 2002; 63(6): 508-512.
23. Post RM, Altshuler LL, Frye MA, et al. Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers. Bipolar Disord 2001; 3(5): 259-265.
24. Berk M, Dodd S. Recent developments in the treatment of bipolar disorders. Expert Opin Invest Drugs 2003; 12(10): 1621-1632.
25. Marneros A, Breiger P. Prognosis of bipolar disorder: a review in bipolar disorder. In: Maj M, Akiskal H, Lopez-Ibor JJ, Sartorius N, eds. Bipolar disorder. Bognor Regis: John Wiley & Sons Ltd, 2002: 97-100.
26. Lingam R, Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr Scand 2002; 105(3): 164-172.
27. Lam DH, Watkins ER, Hayward P, et al. A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year. Arch Gen Psychiatry 2003; 60(2): 145-152.
28. Miklowitz DJ, Richards JA, George EL, et al. Integrated family and individual therapy for bipolar disorder: results of a treatment development study. J Clin Psychiatry 2003; 64(2): 182-191.
29. Frank E, Swartz HA, Kupfer DJ. Interpersonal and social rhythm therapy: managing the chaos of bipolar disorder. Biol Psychiatry 2000; 48(6): 593-604.